Artecef® 150, 1 ml, im-injection

  • Product

    Artecef 150, 1 ml, solution for i.m.-injection

  • Authorisation

    NL-RVG 24881, SA 33/20.2.6./0304

  • Active ingredient

    Artemotil 150 mg in sesame oil

  • Indication

    Severe P. falciparum malaria infection

  • Storage condition

    Between 15 – 25 °C

Artecef 150 is registered for the treatment of severe malaria tropica infections caused by the parasite P. falciparum.

Artecef 150 contains the recommended dose for the treatment of adults.

Artecef 50 and Artecef 150 have been listed as life-saving medication on the Procurementlist of UN-agencies (including UNICEF) after pre-qualification by the WHO (M027 and MA028, 2007).

Legal status

Artecef 150 is a licensed medicine in the Netherlands and South Africa (SA 33/20.2.6./0304).

When this medicine is supplied outside the Netherlands, it is considered to be an unlicensed medicine in the country of the recipient.

Availability for (Hospital) Pharmacies

In the Netherlands, Artecef 150 is distributed to (hospital)pharmacies by the pharmaceutical wholesalers.

(Hospital) Pharmacies outside the Netherlands that would like to know more about the availability of this product are welcome to contact us via our contact form.